PMID- 23884858 OWN - NLM STAT- MEDLINE DCOM- 20131029 LR - 20211203 IS - 1528-0020 (Electronic) IS - 0006-4971 (Linking) VI - 122 IP - 10 DP - 2013 Sep 5 TI - COP1 targets C/EBPalpha for degradation and induces acute myeloid leukemia via Trib1. PG - 1750-60 LID - 10.1182/blood-2012-12-476101 [doi] AB - The ubiquitin ligase constitutively photomorphogenic 1 (COP1) is involved in many biological responses in mammalian cells, but its role in tumorigenesis remains unclear. Here we show that COP1 is a ubiquitin ligase for the tumor suppressor CCAAT/enhancer-binding protein (C/EBPalpha) and promotes its degradation in vivo, thereby blocking myeloid differentiation of hematopoietic cells for tumorigenesis. In this process, mammalian homolog of Tribbles, Trib1, which contains a COP1-binding motif, is essential for down-regulation of C/EBPalpha expression. Murine bone marrow transplantation experiments showed that coexpression of COP1 accelerates development of acute myeloid leukemia induced by Trib1, which pathologically resembles that of p42C/EBPalpha-deficient mice. Interestingly, coexpression of ligase activity-deficient COP1 mutant abrogated Trib1-induced leukemogenesis. These results indicate that COP1 and Trib1 act as an oncoprotein complex functioning upstream of C/EBPalpha, and its ligase activity is crucial for leukemogenesis. FAU - Yoshida, Akihiro AU - Yoshida A AD - Department of Tumor Cell Biology, Graduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma, Nara, Japan. FAU - Kato, Jun-Ya AU - Kato JY FAU - Nakamae, Ikuko AU - Nakamae I FAU - Yoneda-Kato, Noriko AU - Yoneda-Kato N LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130724 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (CCAAT-Enhancer-Binding Protein-alpha) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (Mutant Proteins) RN - 0 (Nuclear Proteins) RN - 0 (Trib1 protein, mouse) RN - 143011-72-7 (Granulocyte Colony-Stimulating Factor) RN - EC 2.3.2.27 (COP1 protein, mouse) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) SB - IM MH - Alternative Splicing/drug effects MH - Animals MH - Bone Marrow Transplantation MH - CCAAT-Enhancer-Binding Protein-alpha/*metabolism MH - Cell Differentiation/drug effects MH - Granulocyte Colony-Stimulating Factor/pharmacology MH - Granulocytes/drug effects/metabolism/pathology MH - HEK293 Cells MH - Humans MH - Intracellular Signaling Peptides and Proteins/*metabolism MH - Leukemia, Myeloid, Acute/*metabolism/*pathology MH - Mice MH - Mice, Inbred C57BL MH - Mutant Proteins/metabolism MH - Mutation/genetics MH - NIH 3T3 Cells MH - Nuclear Proteins/*metabolism MH - Protein Serine-Threonine Kinases/*antagonists & inhibitors/metabolism MH - *Proteolysis/drug effects MH - Ubiquitin-Protein Ligases/*metabolism EDAT- 2013/07/26 06:00 MHDA- 2013/10/30 06:00 CRDT- 2013/07/26 06:00 PHST- 2013/07/26 06:00 [entrez] PHST- 2013/07/26 06:00 [pubmed] PHST- 2013/10/30 06:00 [medline] AID - S0006-4971(20)53514-3 [pii] AID - 10.1182/blood-2012-12-476101 [doi] PST - ppublish SO - Blood. 2013 Sep 5;122(10):1750-60. doi: 10.1182/blood-2012-12-476101. Epub 2013 Jul 24.